Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to -$705047.0.

  • GeoVax Labs' Change in Accured Expenses rose 8072.04% to -$705047.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$783995.0, marking a year-over-year increase of 8247.47%. This contributed to the annual value of -$412549.0 for FY2024, which is 6640.52% up from last year.
  • According to the latest figures from Q3 2025, GeoVax Labs' Change in Accured Expenses is -$705047.0, which was up 8072.04% from -$406110.0 recorded in Q2 2025.
  • In the past 5 years, GeoVax Labs' Change in Accured Expenses ranged from a high of $7.1 million in Q4 2021 and a low of -$3.7 million during Q3 2024
  • In the last 5 years, GeoVax Labs' Change in Accured Expenses had a median value of -$208839.0 in 2023 and averaged $63107.9.
  • In the last 5 years, GeoVax Labs' Change in Accured Expenses soared by 632344.85% in 2021 and then tumbled by 44047.94% in 2022.
  • GeoVax Labs' Change in Accured Expenses (Quarter) stood at $7.1 million in 2021, then tumbled by 128.75% to -$2.0 million in 2022, then crashed by 74.47% to -$3.6 million in 2023, then skyrocketed by 114.01% to $499160.0 in 2024, then crashed by 241.25% to -$705047.0 in 2025.
  • Its Change in Accured Expenses was -$705047.0 in Q3 2025, compared to -$406110.0 in Q2 2025 and -$171998.0 in Q1 2025.